Back to Search Start Over

Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials.

Authors :
Zhang WY
Liu Y
Wang Y
Wang CM
Yang QM
Zhu HL
Han WD
Source :
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2017 Oct 09; Vol. 2, pp. 17054. Date of Electronic Publication: 2017 Oct 09 (Print Publication: 2017).
Publication Year :
2017

Abstract

Competing Interests: The authors declare no conflict of interest.

Details

Language :
English
ISSN :
2095-9907
Volume :
2
Database :
MEDLINE
Journal :
Signal transduction and targeted therapy
Publication Type :
Report
Accession number :
29263931
Full Text :
https://doi.org/10.1038/sigtrans.2017.54